Duncker Streett & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Duncker Streett & Co’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-515	Closed	-$47.7K	–	499
2024 Q2	$47.7K	Hold	515	–	–	0.01%	320
2024 Q1	$48.9K	Hold	515	–	–	0.01%	320
2023 Q4	$46K	Buy	515 +15	+3%	+$1.11K	0.01%	319
2023 Q3	$36.5K	Hold	500	–	–	0.01%	323
2023 Q2	$41.6K	Hold	500	–	–	0.01%	314
2023 Q1	$38.1K	Hold	500	–	–	0.01%	316
2022 Q4	$41.5K	Buy	+500	New	+$40.5K	0.01%	311
2022 Q1	–	Sell	-301	Closed	-$34K	–	526
2021 Q4	$34K	Hold	301	–	–	0.01%	370
2021 Q3	$38K	Hold	301	–	–	0.01%	357
2021 Q2	$41K	Hold	301	–	–	0.01%	353
2021 Q1	$41K	Hold	301	–	–	0.01%	351
2020 Q4	$42K	Buy	+301	New	+$38.6K	0.01%	352
2019 Q3	–	Sell	-300	Closed	-$26K	–	514
2019 Q2	$26K	Hold	300	–	–	0.01%	427
2019 Q1	$27K	Hold	300	–	–	0.01%	425
2018 Q4	$22K	Hold	300	–	–	0.01%	433
2018 Q3	$29K	Hold	300	–	–	0.01%	434
2018 Q2	$29K	Buy	+300	New	+$27.6K	0.01%	432

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Duncker Streett & Co's XBI Position: Q3 2024 in Review

Duncker Streett & Co sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2024, closing a stake of 515 shares — an estimated $47.7K sold.

Duncker Streett & Co first reported a position in XBI in Q2 2018 and held it in 17 quarters. The position peaked at $48.9K in Q1 2024. 770 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

Duncker Streett & Co reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2024 after selling out during the quarter.
Duncker Streett & Co sold 515 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $47.7K.
Duncker Streett & Co first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and held it in 17 quarters.
Duncker Streett & Co's State Street SPDR S&P Biotech ETF position peaked at $48.9K in Q1 2024.
770 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on Duncker Streett & Co's 13F filing for Q3 2024, filed 12 Nov 2024.